IRTC insider buying and SEC filings, explained
iRhythm Holdings, Inc. · CIK 1388658
Tracked: Forms 3/4/5, 8-K, NT · All filings on sec.gov
Company profile
- Exchanges
- Nasdaq
- Industry (SIC)
- Surgical & Medical Instruments & Apparatus
- Fiscal year end
- Dec 31
- Former names
- IRhythm Technologies, Inc.; iRhythm Technologies, Inc.; IRhythm Technologies Inc
Insider activity in the last 12 months
Bought
$0
Insiders who bought
0
Sold (not marked 10b5-1)
$25.2M
Planned sales (10b5-1)
$2.8M
Insider purchases and sales, last 12 months
| Traded | Type | What was filed | Source |
|---|---|---|---|
| Sep 2, 2026 | Sale | Daniel G. Wilson (CFO) sold 773 shares at $121.83 ($94K). Holdings down 2% to 34,887 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Sep 3, 2026 |
| Aug 10, 2026 | Sale | Minang Turakhia (Chief Med/Sci Ofcr EVP Advtech) sold 7,093 shares at $124.65 ($884K). Holdings down 11% to 60,116 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Aug 11, 2026 |
| Aug 10, 2026 | Sale | Sumi Shrishrimal (EVP, Chief Risk Officer) sold 5,372 shares at $124.65 ($670K). Holdings down 11% to 44,621 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Aug 11, 2026 |
| Aug 10, 2026 | Sale | Chad Patterson (Chief Comm & Product Officer) sold 7,093 shares at $124.65 ($884K). Holdings down 10% to 62,125 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Aug 11, 2026 |
| Aug 10, 2026 | Sale | Patrick Michael Murphy (CBO and CLO) sold 7,093 shares at $124.65 ($884K). Holdings down 9% to 69,699 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Aug 11, 2026 |
| Aug 10, 2026 | Sale | Quentin S. Blackford (CEO and Director) sold 26,859 shares at $124.65 ($3.3M). Holdings down 11% to 226,008 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Aug 11, 2026 |
| Aug 3, 2026 | Sale | Julianne Rodda (EVP, Chief People Officer) sold 2,112 shares at $122.12 ($258K). Holdings down 10% to 18,201 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Aug 4, 2026 |
| Aug 3, 2026 | Sale | Mervin Smith (EVP Strategic Business Ops) sold 617 shares at $122.12 ($75K). Holdings down 3% to 22,410 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Aug 4, 2026 |
| Aug 3, 2026 | Sale | Chad Patterson (Chief Comm & Product Officer) sold 2,712 shares at $122.12 ($331K). Holdings down 5% to 55,629 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Aug 4, 2026 |
| Jul 2, 2026 | Sale | Sean Clinton Freeman (EVP, Strategy & Corp Devt) sold 918 shares at $124.71 ($114K). Holdings down 6% to 13,641 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jul 6, 2026 |
| Jul 2, 2026 | Sale | Minang Turakhia (Chief Med/Sci Ofcr EVP Advtech) sold 1,423 shares at $124.71 ($177K). Holdings down 3% to 53,620 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jul 6, 2026 |
| Jun 2, 2026 | Sale | Marc Wade Rosenbaum (Chief Accounting Officer) sold 729 shares at $108.19 ($79K). Holdings down 4% to 16,155 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jun 3, 2026 |
| Jun 2, 2026 | Sale | Sumi Shrishrimal (EVP, Chief Risk Officer) sold 1,716 shares at $108.19 ($186K). Holdings down 4% to 40,287 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Jun 3, 2026 |
| May 11, 2026 | Planned (10b5-1) | Abhijit Y. Talwalkar (Director) sold 5,312 shares at about $117.93 ($626K), marked as a 10b5-1 plan trade. Holdings down 21% to 20,299 shares. | SEC filing Filed May 12, 2026 |
| May 11, 2026 | Purchase (code P) | Abhijit Y. Talwalkar (Director) bought 5,312 shares at $10.71 ($57K), reported as a purchase (code P). Holdings up 26% to 25,611 shares. | SEC filing Filed May 12, 2026 |
| May 4, 2026 | Sale | Brian Lee Lawrence (Chief Technology Officer) sold 1,014 shares at $120.80 ($122K). Holdings down 5% to 20,154 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed May 5, 2026 |
| Mar 16, 2026 | Planned (10b5-1) | Mervin Smith (EVP Strategic Business Ops) sold 2,585 shares at $114.30 ($295K), marked as a 10b5-1 plan trade. Holdings down 10% to 23,027 shares. | SEC filing Filed Mar 17, 2026 |
| Mar 2, 2026 | Sale | Mervin Smith (EVP Strategic Business Ops) sold 1,352 shares at $128.44 ($174K). Holdings down 5% to 25,612 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 3, 2026 |
| Mar 2, 2026 | Sale | Minang Turakhia (Chief Med/Sci Ofcr EVP Advtech) sold 4,027 shares at $128.45 ($517K). Holdings down 7% to 54,906 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 3, 2026 |
| Mar 2, 2026 | Sale | Marc Wade Rosenbaum (Chief Accounting Officer) sold 816 shares at $128.45 ($105K). Holdings down 5% to 16,706 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 3, 2026 |
| Mar 2, 2026 | Sale | Daniel G. Wilson (CFO) sold 3,395 shares at about $128.45 ($436K). Holdings down 9% to 35,660 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 3, 2026 |
| Mar 2, 2026 | Sale | Sumi Shrishrimal (EVP, Chief Risk Officer) sold 2,830 shares at $128.44 ($363K). Holdings down 6% to 41,870 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 3, 2026 |
| Mar 2, 2026 | Sale | Chad Patterson (Chief Comm & Product Officer) sold 4,444 shares at $128.44 ($571K). Holdings down 7% to 58,164 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 3, 2026 |
| Mar 2, 2026 | Sale | Patrick Michael Murphy (CBO and CLO) sold 4,357 shares at about $128.44 ($560K). Holdings down 6% to 63,203 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 3, 2026 |
| Mar 2, 2026 | Sale | Quentin S. Blackford (CEO and Director) sold 13,813 shares at $128.44 ($1.8M). Holdings down 6% to 204,155 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Mar 3, 2026 |
| Feb 25, 2026 | Sale | Mervin Smith (EVP Strategic Business Ops) sold 4,041 shares at $135.42 ($547K). Holdings down 17% to 20,275 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Feb 26, 2026 |
| Feb 25, 2026 | Sale | Minang Turakhia (Chief Med/Sci Ofcr EVP Advtech) sold 7,804 shares at $135.42 ($1.1M). Holdings down 14% to 48,899 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Feb 26, 2026 |
| Feb 25, 2026 | Sale | Marc Wade Rosenbaum (Chief Accounting Officer) sold 4,797 shares at $135.42 ($650K). Holdings down 24% to 15,014 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Feb 26, 2026 |
| Feb 25, 2026 | Sale | Daniel G. Wilson (CFO) sold 5,188 shares at $135.42 ($703K). Holdings down 14% to 30,694 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Feb 26, 2026 |
| Feb 25, 2026 | Sale | Sumi Shrishrimal (EVP, Chief Risk Officer) sold 6,217 shares at $135.42 ($842K). Holdings down 14% to 39,182 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Feb 26, 2026 |
| Feb 25, 2026 | Sale | Chad Patterson (Chief Comm & Product Officer) sold 8,967 shares at $135.42 ($1.2M). Holdings down 15% to 51,738 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Feb 26, 2026 |
| Feb 25, 2026 | Sale | Patrick Michael Murphy (CBO and CLO) sold 7,805 shares at $135.42 ($1.1M). Holdings down 11% to 60,536 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Feb 26, 2026 |
| Feb 25, 2026 | Sale | Quentin S. Blackford (CEO and Director) sold 25,540 shares at $135.42 ($3.5M). Holdings down 12% to 186,126 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Feb 26, 2026 |
| Feb 24, 2026 | Planned (10b5-1) | Mervin Smith (EVP Strategic Business Ops) sold 732 shares at $140.91 ($103K), marked as a 10b5-1 plan trade. Holdings down 5% to 15,106 shares. | SEC filing Filed Feb 25, 2026 |
| Feb 24, 2026 | Planned (10b5-1) | Marc Wade Rosenbaum (Chief Accounting Officer) sold 280 shares at $140.91 ($39K), marked as a 10b5-1 plan trade. Holdings down 3% to 10,601 shares. | SEC filing Filed Feb 25, 2026 |
| Feb 23, 2026 | Planned (10b5-1) | Abhijit Y. Talwalkar (Director) sold 5,312 shares at about $145.71 ($774K), marked as a 10b5-1 plan trade. Holdings down 21% to 20,299 shares. | SEC filing Filed Feb 24, 2026 |
| Dec 2, 2025 | Planned (10b5-1) | Chad Patterson (Chief Comm & Product Officer) sold 280 shares at $184.83 ($52K), marked as a 10b5-1 plan trade. Holdings down 1% to 43,387 shares. | SEC filing Filed Dec 3, 2025 |
| Dec 2, 2025 | Sale | Patrick Michael Murphy (CBO and CLO) sold 2,478 shares at $184.83 ($458K). Holdings down 4% to 53,281 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Dec 3, 2025 |
| Nov 10, 2025 | Planned (10b5-1) | Abhijit Y. Talwalkar (Director) sold 5,312 shares at about $174.13 ($925K), marked as a 10b5-1 plan trade. Holdings down 21% to 20,299 shares. | SEC filing Filed Nov 12, 2025 |
| Nov 3, 2025 | Sale | Quentin S. Blackford (CEO and Director) sold 14,059 shares at $182.94 ($2.6M). Holdings down 8% to 164,979 shares. Not marked as a 10b5-1 plan trade. | SEC filing Filed Nov 4, 2025 |
43 routine transactions (such as grants, option exercises or tax withholding) are not listed.
Cluster buys
No cluster buys in the last 12 months.
Red flags
No red flags in the last 12 months.
Key events
No key events in the last 12 months.
8-K filings, last 12 months
No 8-K filings in the last 12 months.
Red flags are objective triggers only: the item or form filed, never an opinion.
Follow IRTC in the Insider Ledger app
Get the appA plain-English brief of insider purchases, 8-Ks and red flags at the companies you pick. No account needed.